The company provides industrial automation and coding solutions, such as laser and dot peen marking systems for manufacturing, and manages a legacy real estate portfolio including residential developments and IT parks.
The company lacks a durable moat as evidenced by a 30% revenue decline and low net margins of 5.2%, suggesting its industrial marking products are largely commoditized and its real estate earnings are non-recurring.
Capital has been primarily directed toward exiting non-core businesses and completing legacy real estate projects. While the company is now debt-free, the high ROCE is distorted by the demerger of the precision tools business rather than organic reinvestment efficiency.
The investment collapsed as the company failed to replace the lumpy, non-recurring cash flows from its legacy real estate projects, leaving it as a hollowed-out shell of its former self. The massive 30% revenue decline observed in the filings proved to be a terminal trend rather than a cyclical dip, as the commoditized industrial marking business lacked the scale to support the corporate overhead. Management's inability to find a productive use for the remaining cash, coupled with the persistent executive turnover and the eventual crystallization of liabilities from the Svadeshi Mills litigation, eroded the book value until the market finally stopped pricing in a turnaround that never arrived.
RichFakir rates Forbes & Company Ltd's business quality as poor — 36/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Forbes & Company Ltd is trading about 86% above our estimate of fair value; we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Forbes & Company Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Forbes & Company Ltd's fair value is about ₹149 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →